Lv62
1696 积分 2023-05-16 加入
Prediction of Human Pharmacokinetics and Clinical Effective Dose of SI–B001, an EGFR/HER3 Bi-specific Monoclonal Antibody
15天前
已完结
IL-1β–induced STAT3 activation drives IL-17–producing CD8+ tissue-resident memory T cells and exacerbates chronic psoriasis
1个月前
已完结
Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
1个月前
已完结
Comprehensive analysis of phenotypes and transcriptome characteristics reveal the best atopic dermatitis mouse model induced by MC903
1个月前
已完结
Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study
1个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis
2个月前
已完结
Interleukin‐17 is a potential player and treatment target in severe chronic spontaneous urticaria
2个月前
已完结
Targeting Mast Cells in Chronic Spontaneous Urticaria
2个月前
已完结
Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation
3个月前
已完结
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
3个月前
已完结
皖公网安备34019202002308
